Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

NMN 300 mg powder: DSLD label record for California Gold Nutrition

The DSLD record lists a California Gold Nutrition powder labelled NMN 300 mg, with Beta-Nicotinamide Mononucleotide 300 mg per labelled serving. It is a label declaration only, not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
NMN 300 mgOriginal label · NIH DSLD
NMN 300 mg

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
1.05 Ounce(s) · 30 Gram(s)
Label serving
0.34 Gram(s)
Servings per container
88
Barcode / SKU
8 98220 02169 7
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Beta-Nicotinamide Mononucleotide300 mg0.34 Gram(s)

Other ingredients: Silicon Dioxide

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 299660 lists a California Gold Nutrition powder labelled NMN 300 mg, entered 2023-12-14. [1]

  2. The label declares Beta-Nicotinamide Mononucleotide at 300 mg per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
California Gold Nutrition
Form
Powder
Pack contents
1.05 Ounce(s) · 30 Gram(s)
Label serving
0.34 Gram(s)
Ingredients listed
Beta-Nicotinamide Mononucleotide
Record type / format
Dietary supplement label/database record (not a study).
Scope / context
The described product: California Gold Nutrition NMN 300 mg powder, as listed in DSLD record 299660.
Summary based on
Product label / database record

DSLD record 299660 for an NMN powder

This entry comes from the NIH Dietary Supplement Label Database (DSLD), record 299660. The label name is NMN 300 mg and the declared brand is California Gold Nutrition. The physical form on the label is powder, and DSLD places the product in the category Non-Nutrient/Non-Botanical. The label entered DSLD on 2023-12-14; the record notes this is not a product launch date. The database entry describes label declarations only.

Supporting source [1]

Declared ingredient: 300 mg per labelled serving

The only declared ingredient with an amount in this record is Beta-Nicotinamide Mononucleotide, listed at 300 mg per labelled serving. This figure is a label fact, not personal dosing advice. The record supplies no independent product testing, no price and no batch certificate. It also does not state how many servings the package contains or how the powder should be used.

Supporting source [1]

What a DSLD listing does not establish

Inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record is a snapshot of label declarations, so it cannot show whether the product works or is suitable for anyone. The brand name alone does not demonstrate any effect on aging biology.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. No independent testing, price or batch certificate is supplied; amounts are label facts, not dosing advice.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
NMN 300 mg

California Gold Nutrition · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: NMN 300 mg
  2. Finding 2 ↑

    Beta-Nicotinamide Mononucleotide: 300 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…